PT - JOURNAL ARTICLE AU - Lankester, Joanna AU - Guarischi-Sousa, Rodrigo AU - Hilliard, Austin T AU - , AU - Shere, Labiba AU - Husary, Marya AU - Crowe, Susan AU - Tsao, Philip S AU - Rehkopf, David H AU - Assimes, Themistocles L TI - Increased BMI associated with decreased breastfeeding initiation in Million Veteran Program participants AID - 10.1101/2024.07.02.24309047 DP - 2024 Jan 01 TA - medRxiv PG - 2024.07.02.24309047 4099 - http://medrxiv.org/content/early/2024/07/03/2024.07.02.24309047.short 4100 - http://medrxiv.org/content/early/2024/07/03/2024.07.02.24309047.full AB - Background Breastfeeding has been associated with maternal and infant health benefits but has been inversely associated with body mass index (BMI) prepartum. Breastfeeding and BMI are both linked to socioeconomic factors.Methods Data from parous female participants with available breastfeeding information from the Million Veteran Program cohort was included. BMI at enrollment and earliest BMI available were extracted, and polygenic scores (PGS) for BMI were calculated. We modeled breastfeeding for one month or more as a function of BMI at enrollment; earliest BMI where available pre-pregnancy; and PGS for BMI. We conducted Mendelian randomization for breastfeeding initiation using PGS as an instrumental variable.Results A higher BMI predicted a lower likelihood of breastfeeding for one month or more in all analyses. A +5 kg/m2 BMI pre-pregnancy was associated with a 24% reduced odds of breastfeeding, and a +5 kg/m2 genetically predicted BMI was associated with a 17% reduced odds of breastfeeding.Conclusions BMI predicts a lower likelihood of breastfeeding for one month or longer. Given the high success of breastfeeding initiation regardless of BMI in supportive environments as well as potential health benefits, patients with elevated BMI may benefit from additional postpartum breastfeeding support.Competing Interest StatementThe authors have declared no competing interest.Funding StatementJL is supported by the Big Data Scientific Training Enhancement Program (BD-STEP) through the Veterans Affairs and National Cancer Institute. TLA is supported by a grant from the National Institute of Diabetes and Digestive and Kidney Diseases (R01DK114183). This research is based on data from the Million Veteran Program, Office of Research and Development, Veterans Health Administration, and was supported by Veterans Administration awards I01-01BX003362. The content of this manuscript does not represent the views of the Department of Veterans Affairs or the United States Government.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study received ethical and study protocol approval from the U.S. Veterans Affairs Central Institutional Review Board.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAccess to individual level data used in the present work requires approval by the U.S. Veterans Administration.